Surgical microwave ablation for multifocal non-resectable liver metastases: a single institution experience treating five or more liver lesions

医学 微波消融 烧蚀 外科 结直肠癌 阶段(地层学) 回顾性队列研究 癌症 队列 放射科
作者
Jillian K. Wothe,Kendall R. McEachron,Schelomo Marmor,Jacob S. Ankeny,Christopher J. LaRocca,Benjamin Spilseth,Robben Schat,Eric H. Jensen
出处
期刊:Journal of gastrointestinal oncology [AME Publishing Company]
标识
DOI:10.21037/jgo-21-203
摘要

Thermal ablation is an effective treatment for patients with metastatic colon and rectal cancer and allows surgeons to offer curative intent therapy to patients who are otherwise not candidates for resection. We aimed to report outcomes of a single institution experience using microwave ablation (MWA) with or without resection to treat five or more liver metastases.In this retrospective cohort study, the University of Minnesota Division of Surgical Oncology liver surgery database was queried to identify all patients who underwent thermal ablation of five or more colorectal liver metastases (CRLM) between 2012-2018. We reviewed patient, disease, and tumor characteristics and measured local, intrahepatic, and extrahepatic recurrence (EHR) rates. We also calculated median overall survival (OS) and disease-free survival (DFS).Ten patients identified had five or more (range, 5-18) tumors ablated with or without combined liver and bowel resection. Median age was 50, and most patients were male (70%) and Caucasian (90%). Four patients received ablation alone (5-12 lesions), while six had combined resection and ablation (5-18 lesions). Ablation was performed laparoscopically in six patients, and four had ablations without resection. All patients received pre- and post-operative chemotherapy. A median of 7 tumors were ablated per patient. Median follow-up was 2.3 years. Among 75 tumors ablated, ablation site recurrence (ASR) (within 1 cm of ablation site) was seen in three with a per-lesion recurrence rate of 4%. Intrahepatic recurrence (IHR) occurred in 6 (60%) patients and EHR in 1 (10%). Five patients underwent retreatment of IHR during follow-up. Median OS was 3 years and DFS was 7.1 months. At the time of last follow up, 6 patients were disease-free.Thermal ablation can provide acceptable DFS and OS, even with high volume metastatic colorectal cancers. Future efforts should be focused on defining selection criteria for those most likely to benefit from this aggressive approach.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
a雪橙发布了新的文献求助10
2秒前
无花果的应助被Cindy采纳,获得10
4秒前
科研通AI6.2的应助被荔枝励志采纳,获得10
4秒前
ShenghuiH发布了新的文献求助10
5秒前
6秒前
情怀的应助被deng采纳,获得10
7秒前
nana发布了新的文献求助10
9秒前
FJ发布了新的文献求助10
11秒前
11秒前
沉默毛巾完成签到,获得积分10
13秒前
14秒前
Cindy发布了新的文献求助10
15秒前
大气的莆完成签到,获得积分10
17秒前
closer完成签到 ,获得积分10
18秒前
弥七的应助被友好的哈密瓜采纳,获得10
18秒前
18秒前
li发布了新的文献求助10
19秒前
Eason_C完成签到 ,获得积分10
20秒前
20秒前
科研通AI6.2的应助被ShenghuiH采纳,获得10
20秒前
科研通AI6.2的应助被Wo了喝采纳,获得10
23秒前
清脆缘分发布了新的文献求助10
25秒前
勤奋尔丝完成签到 ,获得积分10
27秒前
热情曲奇完成签到,获得积分10
27秒前
28秒前
CodeCraft的应助被科研通管家采纳,获得10
28秒前
汉堡包的应助被科研通管家采纳,获得10
28秒前
不留名的应助被科研通管家采纳,获得10
28秒前
Orange的应助被科研通管家采纳,获得10
28秒前
SciGPT的应助被科研通管家采纳,获得10
28秒前
Lny的应助被科研通管家采纳,获得10
28秒前
无花果的应助被科研通管家采纳,获得10
29秒前
8R60d8的应助被科研通管家采纳,获得10
29秒前
CodeCraft的应助被科研通管家采纳,获得10
29秒前
乐乐的应助被科研通管家采纳,获得10
29秒前
29秒前
英俊的铭的应助被科研通管家采纳,获得10
29秒前
不留名的应助被科研通管家采纳,获得10
29秒前
wanci的应助被科研通管家采纳,获得10
30秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
自動車の空力技術 800
Essentials of Carbohydrate Chemistry and Biochemistry, 4th Edition 800
Organizational Behavior 510
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Issues in Task-Based Language Teaching 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 化学工程 工程类 有机化学 物理 复合材料 生物化学 内科学 细胞生物学 基因 遗传学 免疫学 冶金 光电子学 癌症研究
热门帖子
关注 科研通微信公众号,转发送积分 7783307
求助须知:如何正确求助?哪些是违规求助? 9322663
关于积分的说明 20391034
捐赠科研通 7372037
什么是DOI,文献DOI怎么找? 3320643
关于科研通互助平台的介绍 2468660
邀请新用户注册赠送积分活动 2336896